Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Novel Technique Allows Genome Sequencing of Single Malaria Cells

By BiotechDaily International staff writers
Posted on 18 May 2014
Image: Graphic of the malaria parasite Plasmodium in a red
blood cell (Photo courtesy of Simon Levey).
Image: Graphic of the malaria parasite Plasmodium in a red
blood cell (Photo courtesy of Simon Levey).
A recently developed technique for analyzing the genome of a malaria parasite within a single red blood cell is expected to aid in the understanding of the molecular cell biology of these organisms and in the design of new drugs to prevent their growth and spread.

Investigators at the Texas Biomedical Research Institute (San Antonio, USA) combined advanced cell sorting technology and whole-genome amplification (WGA) to generate high-quality DNA samples from parasite-infected red blood cells (RBCs) for genotyping and next-generation sequencing. They optimized this approach through analysis of more than 260 single-cell assays, and quantified accuracy by decomposing mixtures of known parasite genotypes and obtaining highly accurate (> 99%) single-cell genotypes.

The investigators applied this validated approach directly to infections of two major malaria species, Plasmodium falciparum, for which long term culture is possible, and Plasmodium vivax, for which no long-term culture is feasible. They demonstrated that the single-cell genomics approach could be used to generate parasite genome sequences directly from patient blood in order to unravel the complexity of P. vivax and P. falciparum infections.

Malaria parasite infections are complex and often contain multiple different parasite genotypes and even different parasite species. "This has really limited our understanding of malaria parasite biology" said senior author Dr. Ian Cheeseman, a postdoctoral scientist in the genetics department of the Texas Biomedical Research Institute. “It is like trying to understand human genetics by making DNA from everyone in a village at once. The data is all jumbled up – what we really want is information from individuals. We are now able to look at malaria infections with incredible detail. This will help us understand how to best design drugs and vaccines to tackle this major global killer.”

The study describing the novel single-cell approach for genome sequencing was published in the May 8, 2014, online edition of the journal Genome Research.

Related Links:

Texas Biomedical Research Institute



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Lab Technologies

view channel

Genome-Wide Mutation-Searching Computational Software Designed for Genomic Medicine

Analysis software cross-references a patient’s symptoms with his genome sequence to help physicians in the diagnosis of disease. This software was created by a team of scientists from A*STAR’s Genome Institute of Singapore (GIS), led by Dr. Pauline Ng. The research findings were published August 3, 2014, in the journal... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.